학술논문

Antimicrobial and proinflammatory effects of two vipericidins.
Document Type
Article
Source
Cytokine. Nov2018, Vol. 111, p309-316. 8p.
Subject
*ANTI-infective agents
*MULTIDRUG resistance in bacteria
*CELL-mediated cytotoxicity
*INFLAMMATION
*TUMOR necrosis factors
*CATHELICIDINS
Language
ISSN
1043-4666
Abstract
Graphical abstract Highlights • Peptides present great antimicrobial activity against multi drug resistant bacteria. • No cytotoxicity was observed for both peptides after 72 h. • Peptides induce pro-inflammatory effect on Raw 264.7 cells in the presence several stimuli. Abstract Hospital infections allied to bacterial resistance to antibiotics have become a major worldwide problem. In this context, antimicrobial peptides (AMPs) are presented as an alternative in the control of these resistant organisms. Besides antimicrobial effects, these molecules play a crucial role in immunity by acting as immunomodulators. These peptides can activate inflammatory cells to produce pro- and anti-inflammatory mediators. In this study we will show the activity against multi-drug resistant bacteria (MDRB) of two cathelicidins from South American pit vipers Bothrops atrox and Crotalus durissus terrificus, named batroxicidin and crotalicidin. It was observed that both peptides showed activity against MDRB and presented no hemolytic or cytotoxic activity. In addition, the ability of peptides to modulate the production of cytokines TNF-α, IL-10 and IL-6 was analyzed using Raw 264.7 cells in the presence of IFN-γ stimuli, and multi-resistant E. coli and K. pneumoniae antigens. An up-expression or down-expression of TNF-α, as well as the IL-10 mediator, was observed. The cytokine IL-6, on the other hand, presented only a down-regulation for Raw 264.7 cell groups. In conclusion, the results demonstrate that both peptides presented a predominantly proinflammatory characteristic to the inflammatory mediators dosed. Overall, even presenting a proinflammatory characteristic, these peptides are still promising for future research and development of new potential antimicrobial molecules. [ABSTRACT FROM AUTHOR]